Close



Mar 25, 2024 10:34PM
Mar 13, 2024 07:30PM
Mar 10, 2024 07:55PM
Mar 10, 2024 07:54PM
Feb 28, 2024 05:57PM
Feb 14, 2024 07:46PM
Jan 30, 2024 09:13PM Appendix 4C Quarterly Activity Report for Quarter Ended December 31, 2023
Jan 18, 2024 06:36PM
Nov 26, 2023 06:56PM
Nov 21, 2023 06:32PM
Oct 30, 2023 08:04PM
Sep 21, 2023 03:30AM
Aug 30, 2023 07:07PM
Aug 3, 2023 08:10PM Mesoblast Receives Complete Response From U.S. Food and Drug Administration for Biologics License Application for Steroid-Refractory Acute Graft Versus Host Disease in Children
Jul 30, 2023 08:31PM
Jul 5, 2023 08:30AM
Jun 4, 2023 08:21PM
May 25, 2023 07:28PM
Apr 27, 2023 09:00PM
Apr 25, 2023 08:47PM
Mar 21, 2023 09:20PM FDA Schedules Pre-License Inspection of Remestemcel-L Manufacturing
Mar 7, 2023 07:03PM
Feb 27, 2023 05:13PM
Feb 27, 2023 04:50PM
Feb 27, 2023 04:49PM
Feb 16, 2023 06:16PM
Feb 8, 2023 06:09PM
Jan 31, 2023 06:30PM Mesoblast Resubmits Biologic License Application (BLA) to FDA for Remestemcel-L in Children With Steroid-Refractory Acute Graft Versus Host Disease (Sr-aGVHD)
Jan 31, 2023 04:40AM
Nov 22, 2022 06:32PM
Nov 22, 2022 06:00PM
Oct 30, 2022 07:50PM
Oct 2, 2022 07:51PM
Aug 30, 2022 07:05PM
Aug 18, 2022 07:00AM Jane Bell Joins Mesoblast Board
Jul 29, 2022 07:05AM
Jul 11, 2022 08:40PM
Apr 28, 2022 08:35PM
Mar 23, 2022 08:40PM
Feb 24, 2022 05:30PM
Feb 20, 2022 06:19PM
Feb 1, 2022 07:20PM Mesoblast Appoints Dr. Eric Rose as Chief Medical Officer
Jan 30, 2022 07:16PM
Jan 11, 2022 08:26PM
Dec 30, 2021 06:38PM
Dec 15, 2021 07:09PM
Dec 5, 2021 06:47PM
Nov 23, 2021 06:09PM
Nov 14, 2021 07:13PM Late Breaking Presentation at American Heart Association Annual Meeting of Landmark Phase 3 Trial of Rexlemestrocel-L in Chronic Heart Failure
Oct 28, 2021 07:51PM

251,875 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All